◆ SpookStack

To: Washington i ® From: Washington Field Re: 279A-WF-222936-USAMRIID, 1/11/2006 be - Test and_compare the following diagnostic assays: buF - Develop new, more sensitive B. anthracis detection technologies - Search,for early pathologic, physiologic, or clinical disease markers that may support the results of various diagnostic assays or provide new diagnostic indices. Experimental Design: Nine anthrax-naive, non-human primates (possibly six additional animals, see below) will be expo i 9/14/1999 Exp 9-044, Proto =02 PI: Tech: Ba A tock 1029 _ room|] Hood 1, 9 NHPs exposed bo 4.4% efu/ml, 10.0 x 10’ cfu/ml, b7F 13.8 x 10’ cfu/ml, 10.8 x 10’ cfu/ml, 13.8 x 10’ cfu/ml, 10.8 x 107’ cfu/ml, 11.2 x 10’ cfu/ml, 13.8 x 107 cfu/ml, 7.4 x 10’ cfu/ml, 11.2 x 10’ cfu/ml, 7.2 x 107 cfu/ml 13